Joanna Lewek

TL;DR: Diabetes, elevated level of CRP and troponin, heart rate variability parameters and worsening of left ventricular ejection fraction are related to the severity of cardiovascular complications following COVID-19 infection.

TL;DR: The global coronavirus disease disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronivirus started in March 2020 as mentioned in this paper, and the conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, underlying cardiovascular disease, are particularly vulnerable to the severe course of COVID-2019.

TL;DR: This study presents the prevalence of different CV risk factors, with special emphasis on lipid disorders, and it assesses the relationship between inflammation, oxidative stress, and mutations in genes encoding proteins regulating lipid metabolism, as well as genes conferring susceptibility to cardiovascular, cardiometabolic, and related diseases.

TL;DR: There are only four drugs dedicated to immediate blood pressure lowering in patients with malignant hypertension, including ‘first-line’ and alternative drugs, and a review aims to discuss all those drugs and gives practical suggestions on how to properly use them.